DocGo's shares have plummeted over 45% since mid-February, declining over 20% after reporting Q4 '24 on February 27th. The company has relied on contingencies such as COVID-19 testing and large contracts for a significant part of its revenues, much of which has now dried up. The company is transitioning to a new revenue model targeting Health Insurance Partnerships, aiming for more stable and predictable revenues. Yet, this space is highly competitive.
Motion Acquisition (DCGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2024 after the markets close on Thursday, February 27, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, February 27, 2025 5:00.
DocGo (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will hold a fireside chat at the Needham Annual Growth Conference on Wednesday, January 15th at 12:45 – 1:25 PM Eastern Time, and will be participating in 1x1 meetings at this event. A webcast of the fireside chat will be available on the investor relations section of DocGo's website at https://ir.docgo.com/.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary signed a two-year renewal of its contract with a major Tennessee healthcare system. This renewal, building on a six-year partnership, highlights the Company's reliability in delivering efficient and high-quality medical transportation services. Under the renewed agreement, Ambulnz by DocGo will continue prov.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that its Cardiac RMS subsidiary has signed a new contract with one of the largest hospital systems in Mississippi. Under the agreement, in early 2025 Cardiac RMS by DocGo is scheduled to begin providing remote monitoring for nearly 3,000 patients with cardiac implantable electronic devices (“CIEDs”). This new contract marks Cardiac RMS.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced a new contract for ambulance transport services with one of the largest health and hospital systems in North Texas. Under this contract, DocGo's subsidiary EMS Direct is providing Basic Life Support, Advanced Life Support, and Critical Care transportation services to Fort Worth facilities. This agreement was signed and operationalized.
DocGo, Inc. (NASDAQ:DCGO ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Michael Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Pito Chickering - Deutsche Bank Ryan MacDonald - Needham Operator Welcome to DocGo, Inc. Third Quarter 2024 Earnings Call. [Operator Instructions].
DocGo Inc. (DCGO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.05 per share a year ago.